Imagenetix, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IAGX research report →
Companywww.imagenetix.net
Imagenetix, Inc. develops, formulates, and markets proprietary and natural based nutritional supplements, and over-the-counter topical creams and skin care products. Its primary product is Celadrin, a product formulation for joint health.
- CEO
- Decky Goodrich
- IPO
- 2000
- Employees
- 5
- HQ
- San Diego, CA, US
Price Chart
Valuation
- Market Cap
- $2.84K
- P/E
- -0.13
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -3.36
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 41.59%
- Op Margin
- 1.74%
- Net Margin
- -2.63%
- ROE
- -3.39%
- ROIC
- 0.17%
Growth & Income
- Revenue
- $824.50K · 0.00%
- Net Income
- $-21,712 · 0.00%
- EPS
- $-0.00 · 0.00%
- Op Income
- $14.35K
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -406.06
- Avg Volume
- 1.11K
Get TickerSpark's AI analysis on IAGX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IAGX Coverage
We haven't published any research on IAGX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IAGX Report →